Virus News and Research

Latest Virus News and Research

HPV testing for cervical screening saves women from more invasive tests

Testing for the human papillomavirus (HPV) as part of cervical screening reduces the number of women unnecessarily going on for further tests by over a third, new research shows today.

28 Sep 2011

MicroDose initiates MDT-637 Phase 1 trial in respiratory syncytial virus

MicroDose Therapeutx, Inc. today announced that the first human subject has been dosed in a Phase 1 clinical trial of MDT-637, MicroDose's inhalable small molecule antiviral fusion inhibitor for the treatment of respiratory syncytial virus.

28 Sep 2011

Methodist Hospital internist offers few simple suggestions to prevent cold and flu

The first few breezes of fall bring with them not only the promise of a welcome change in season, but also the threat of colds and flu. Dr. Joshua Septimus, an internist at The Methodist Hospital in Houston, offers a few simple suggestions to protect you and your family this cold and flu season. "The most useful tip I can pass along is to wash your hands," says Septimus. "It sounds so simple, but it is truly the most important thing you can do to protect yourself."

27 Sep 2011

Lead compound activates infection-fighting REDD1 protein and kills flu strain

A compound tested by UT Southwestern Medical Center investigators destroys several viruses, including the deadly Spanish flu that killed an estimated 30 million people in the worldwide pandemic of 1918.

27 Sep 2011

Researchers modify HIV in a way that makes it no longer able to suppress immune system

Researchers at Johns Hopkins have modified HIV in a way that makes it no longer able to suppress the immune system. Their work, they say in a report published online September 19 in the journal Blood, could remove a major hurdle in HIV vaccine development and lead to new treatments.

27 Sep 2011

University of Zurich receives AICR grant to improve vaccines against Burkitt's lymphoma

Research in Switzerland could help reduce the time taken to develop vaccines against cancer tumours.

27 Sep 2011

Pakistan officials ask for international assistance as dengue fever outbreak overwhelms local resources

BBC News reports on a continuing outbreak of dengue fever in Pakistan's Punjab province, where "more than 8,000 cases of dengue fever have been reported in the province so far -- 7,000 in Lahore alone -- and the count continues to rise," according to the Punjab health department. According to the news service, "Doctors say more than 30 people have died of the fever so far" in the province, and "health officials estimate that more than 7,000 people are being tested daily for the virus -- 300 to 400 test positive each day".

27 Sep 2011

MSU creates new malaria vaccine with immune-stimulating gene

Continuing a global effort to prevent malaria infections, Michigan State University researchers have created a new malaria vaccine - one that combines the use of a disabled cold virus with an immune system-stimulating gene - that appears to increase the immune response against the parasite that causes the deadly disease.

27 Sep 2011

Alnylam commences ALN-PCS Phase I trial in severe hypercholesterolemia

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-PCS, an RNAi therapeutic targeting proprotein convertase subtilisin/kexin type 9, or PCSK9, for the treatment of severe hypercholesterolemia.

27 Sep 2011

Asthma patients admitted to hospital with H1N1 are half as likely to die from infection

People with asthma who are admitted to hospital with pandemic influenza H1N1 (swine flu) are half as likely to die or require intensive care than those without asthma, according to new research.

26 Sep 2011

Rotavirus vaccine saved 65,000 hospitalizations and $278 million in healthcare costs: Study

The latest research shows that since the 2006 introduction of routine inoculation against rotavirus -- a leading cause of diarrhea in infants and young children -- almost 65,000 fewer American children have been hospitalized and about $278 million in healthcare costs have been saved.

26 Sep 2011

Synthetic lectins inhibit HIV from entering cells

University of Utah researchers have discovered a new class of compounds that stick to the sugary coating of the AIDS virus and inhibit it from infecting cells - an early step toward a new treatment to prevent sexual transmission of the virus.

23 Sep 2011

FDA denies FOIA regarding Gilead Sciences' Truvada correspondence, AHF sues

AIDS Healthcare Foundation (AHF) today filed a lawsuit against the Food and Drug Administration (FDA) over its denial of AHF's Freedom of Information Act (FOIA) requests regarding correspondence between the FDA and Gilead Sciences regarding its potential application to the FDA to expand the use of its AIDS drug, Truvada, for use as an HIV prevention pill for pre-exposure prophylaxis (PrEP) in uninfected individuals.

23 Sep 2011

National HIV/AIDS Strategy meeting to be held at UAB

The White House Office of National AIDS Policy is holding a series of National HIV/AIDS Strategy Implementation Dialogues across the country to examine critical issues and encourage action and collaboration at the state and local levels. The first meeting, focusing on incorporating prevention and care research into HIV programs, is being held at the University of Alabama at Birmingham on Tuesday, Sept. 27, 2011.

23 Sep 2011

IU professor to study factors influencing young women's adoption of HPV vaccine

Dena S. Cox, a professor of marketing and faculty fellow at the Kelley School of Business Indianapolis, has received a $99,600, two-year research grant from Merck to study factors influencing young women's adoption of the human papillomavirus (HPV) vaccine.

23 Sep 2011

NIH honors Utah biochemist with Pioneer Award for dsRNA research

University of Utah biochemist Brenda L. Bass, Ph.D., has dedicated her career to following the path less traveled.

23 Sep 2011

New microbicide may block AIDS virus from infecting cells

23 Sep 2011

Adeno-associated virus type 2 kills human breast cancer cells in lab

A nondisease-causing virus kills human breast cancer cells in the laboratory, creating opportunities for potential new cancer therapies, according to Penn State College of Medicine researchers who tested the virus on three different breast cancer types that represent the multiple stages of breast cancer development.

23 Sep 2011

Preclinical data from two Pulmatrix's PUR118 study to be presented at ERS 2011

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases, today announced that data from two preclinical studies of its inhaled clinical drug candidate, PUR118, will be presented at The European Respiratory Society Annual Congress (ERS 2011), being held September 24-28, 2011, in Amsterdam, Netherlands.

23 Sep 2011

AGTC receives FFB grant to evaluate gene therapy treatment for X-linked Retinoschisis

Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1.5 million from the Foundation Fighting Blindness to fund a pre-clinical trial evaluating the safety and efficacy of a gene therapy treatment for X-linked Retinoschisis (XLRS), a genetic eye disease affecting over 35,000 patients in the US and Europe.

22 Sep 2011

Virus News and Research

Latest Virus News and Research

HPV testing for cervical screening saves women from more invasive tests

MicroDose initiates MDT-637 Phase 1 trial in respiratory syncytial virus

Methodist Hospital internist offers few simple suggestions to prevent cold and flu

Lead compound activates infection-fighting REDD1 protein and kills flu strain

Researchers modify HIV in a way that makes it no longer able to suppress immune system

University of Zurich receives AICR grant to improve vaccines against Burkitt's lymphoma

Pakistan officials ask for international assistance as dengue fever outbreak overwhelms local resources

MSU creates new malaria vaccine with immune-stimulating gene

Alnylam commences ALN-PCS Phase I trial in severe hypercholesterolemia

Asthma patients admitted to hospital with H1N1 are half as likely to die from infection

Rotavirus vaccine saved 65,000 hospitalizations and $278 million in healthcare costs: Study

Synthetic lectins inhibit HIV from entering cells

FDA denies FOIA regarding Gilead Sciences' Truvada correspondence, AHF sues

National HIV/AIDS Strategy meeting to be held at UAB

IU professor to study factors influencing young women's adoption of HPV vaccine

NIH honors Utah biochemist with Pioneer Award for dsRNA research

New microbicide may block AIDS virus from infecting cells

Adeno-associated virus type 2 kills human breast cancer cells in lab

Preclinical data from two Pulmatrix's PUR118 study to be presented at ERS 2011

AGTC receives FFB grant to evaluate gene therapy treatment for X-linked Retinoschisis

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in